1-7 of 7
Lauriane Clement Filliatre
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study

Laure Vincent, Anne Charvet-Rumpler, Lotfi Benboubker, Claire Calmettes, Anne-Marie Stoppa, Kamel Laribi, Lauriane Clement Filliatre, Fressia Honeyman, Richez Valentine, Cyrille Hulin, Frédéric Maloisel, Margaret Macro, Lionel Karlin, Vanessa Barué, Christos Chouaid, Hacène Zerazhi, Xavier Leleu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4312–4314.
https://doi.org/10.1182/blood-2022-157942
Published: 2022
Journal Articles

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma

Clinical Trials & Observations Brief Report
Jill Corre, Aurore Perrot, Denis Caillot, Karim Belhadj, Cyrille Hulin, Xavier Leleu, Mohamad Mohty, Thierry Facon, Laure Buisson, Laura Do Souto, Romain Lannes, Stephanie Dufrechou, Naïs Prade, Frederique Orsini-Piocelle, Laurent Voillat, Arnaud Jaccard, Lionel Karlin, Margaret Macro, Sabine Brechignac, Mamoun Dib, Laurence Sanhes, Jean Fontan, Lauriane Clement-Filliatre, Jean-Pierre Marolleau, Stephane Minvielle, Philippe Moreau, Hervé Avet-Loiseau
Journal: Blood
Blood (2021) 137 (9): 1192–1195.
https://doi.org/10.1182/blood.2020008346
Published: 2021
Includes: Supplemental data
Journal Articles

Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

Aurore Perrot, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, MD, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro, Olivier Decaux, Karim Belhadj, Mohamad Mohty, Lionel Karlin, MD, Jean Claude Eisenmann, Mourad Tiab, Frederique Orsini, Cyrille Touzeau, Xavier Leleu, MD, Herve Avet-Loiseau, Nikhil C. Munshi, MD, Kenneth Anderson, MD, Paul G. Richardson, MD, Philippe Moreau, MD, Michel Attal
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-134538
Published: 2020
Journal Articles

Amahrelis : Adcetris Maintenance after Autologous Stem Cell Transplantation in Hodgkin Lymphoma : A Real Life Study from Sfgmtc and Lysa Groups

Amira Marouf, Anne Ségolène Cottereau, MD, Guillemette Fouquet, MD, Salim Kanoun, MD, Patricia Franchi, MD, Romain Ricci, Michel Meignan, MD, David Sibon, MD PhD, Thomas Gastinne, MD, Cecile Borel, MD, Mohammad Hammoud, MD, Guillaume Sicard, MD, Romane Gille, Doriane Cavalieri, MD, Aspasia Stamatoulas Bastard, MD, Lauriane Clement-Filliatre, MD, Julien Lazarovici, MD, Adrien Chauchet, MD, Luc Mathieu Fornecker, MD PhD, Sandy Amorin, MD, Mathieu Roquet, Nicole Raus, Data Manager, Rene-Olivier Casasnovas, MD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Pauline Brice, MD, Olivier Hermine, Didier Bouscary, MDPhD, Marie Thérèse Rubio, MD PhD, Jerome Tamburini, MD PhD, Benedicte Deau Fischer
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138666
Published: 2020
Journal Articles

Subcutaneous Daratumumab (DARA SC) Plus Standard-of-Care (SoC) Regimens in Multiple Myeloma (MM) across Lines of Therapy in the Phase 2 Pleiades Study: Initial Results of the Dara SC Plus Carfilzomib/Dexamethasone (D-Kd) Cohort, and Updated Results for the Dara SC Plus Bortezomib/Melphalan/Prednisone (D-VMP) and Dara SC Plus Lenalidomide/Dexamethasone (D-Rd) Cohorts

Philippe Moreau, MD, Ajai Chari, Mathias Haenel, MD, Albert Oriol, Paula Rodriguez-Otero, MD PhD, Helen McCarthy, PhD FRCPath, Kenshi Suzuki, MD PhD, Vania T. M. Hungria, MD PhD, Anna Sureda Balari, MD PhD, Lauriane Clement-Filliatre, MD, Cyrille Hulin, MD, Hila Magen, MD, Shinsuke Iida, MD PhD, Vladimir Maisnar, MD, Lionel Karlin, MD, Luděk Pour, MD, Cyrille Touzeau, Shiyi Yang, Michele Kosh, Maria Delioukina, Christoph Heuck, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-134935
Published: 2020
Journal Articles

Real-Life-Setting Effectiveness of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: The Remix Study

Lauriane Clement-Filliatre, MD, Lotfi Benboubker, MD, Anne-Marie Stoppa, Philippe Rodon, MD, Kamel Laribi, MD, Laure Vincent, Philippe Collet, Valentine Richez, MD, Anne Charvet-Rumpler, Hacene Zerazhi, MD, Cyrille Hulin, MD, Frederic Maloisel, MD PhD, Margaret Macro, Lionel Karlin, MD, Nathalie Texier, Christos Chouaid, Xavier Leleu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-133807
Published: 2020
Journal Articles

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study

Aspasia Stamatoullas, MD, Herv Ghesquieres, Lauriane Clement filliatre, MD, Philippe Quittet, MD, Franck Morschhauser, MD, Vincent Ribrag, MD, Veronique Edeline, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 132.
https://doi.org/10.1182/blood-2019-123925
Published: 2019